All Comments by

  1. Richard C. Mohs on Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.
  2. Chris Exley on Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice.
  3. Lary Walker on Seeded Aggregation and Transmissible Proteopathy—Creepy Stuff Not Just for Prions Anymore?
  4. Michael Greicius on Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.
  5. Martin Farlow on Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.
  6. David Knopman on Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.
  7. Veronique Dorval on Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes.
  8. Christopher Nowinski on Brief: NFL Survey on Dementia Splashes Across Front Pages
  9. Ann McKee on Brief: NFL Survey on Dementia Splashes Across Front Pages
  10. Masood Kamali-Moghaddam on Stayin’ Alive—Huge Study Quickens Quest for Plasma AD Biomarker
  11. Iliya Lefterov on Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes.
  12. Markus Britschgi on Seeded Aggregation and Transmissible Proteopathy—Creepy Stuff Not Just for Prions Anymore?
  13. Harry LeVine III on Seeded Aggregation and Transmissible Proteopathy—Creepy Stuff Not Just for Prions Anymore?
  14. James Bergey on Seeded Aggregation and Transmissible Proteopathy—Creepy Stuff Not Just for Prions Anymore?
  15. Philip Scheltens on The prevalence of cortical gray matter atrophy may be overestimated in the healthy aging brain.